Protalix Biotherapeutics Inc (NYSE:PLX) Receives CRL For Its BLA For PRX–102...
Protalix Biotherapeutics Inc (NYSE:PLX) received CRL (complete response letter) from the US FDA for its BLA (Biologics License Application) for PRX-102 (pegunigalsidase alfa) on...
DIH Holding US, Inc. (DHAI): Pioneering Rehabilitation with Cutting-Edge Technology
Let’s talk about something truly inspiring: the future of rehabilitation. On December 23, 2024, DIH Holding US, Inc. (NASDAQ: DHAI) announced...
Predictive Oncology Inc. (Nasdaq: POAI): A Transformative Acquisition by Renovaro Inc.
The biotechnological domain is currently abuzz with developments surrounding the acquisition of Predictive Oncology Inc. (Nasdaq: POAI) by Renovaro Inc. (Nasdaq: RENB)....
Popular News
Eos Energy Enterprises (EOSE) could be just getting primed for a...
Eos Energy Enterprises, Inc. (EOSE) added double digit gains on Friday and last traded at $1.9500, +0.4200 (+27.45%). More than 13,108,341 shares...
MAKE IT MODERN
LATEST REVIEWS
Arca Biopharma Inc (NASDAQ: ABIO) Announces the Results for ASPEN-COVID-19
Arca Biopharma Inc (NASDAQ: ABIO) announced its ASPEN-COVID-19 results. The phase IIb study had 160 patients and investigated rNAPc, that treats patients with COVID-19....
MAKE IT MODERN
PERFORMANCE TRAINING
Applied Therapeutics Surges on Positive FDA Update for Govorestat
Applied Therapeutics (APLT) saw its stock price jump over 68% on September 18th, 2024, following a positive update on the regulatory pathway...
Tech Driven Rally Set to Squeeze Invesco QQQ higher (MNDY,LLY,AFRM)
The QQQ’s are slightly higher this morning as the semiconductors are mixed and trying to find a direction this morning after gapping...
Aptorum Group Limited (NASDAQ:APM) Unveils Infectious Disease Liquid Biopsy Subsidiary to Co-develop RPIDD Tech
Aptorum Group Limited (NASDAQ:APM) has announced the launch of Aptorum Innovations to co-develop a proprietary molecular rapid pathogen identification and detection diagnostics (RPIDD) technology.
Aptorum...
ADMA Biologics Inc (NASDAQ:ADMA) Posts A Growth Of 19% In Q2 2020 Revenues
ADMA Biologics Inc (NASDAQ:ADMA) reported an increase of 19% YoY to $7.8 million in Q2 2020. It is mainly on the backdrop of increased...
Why ISWH is Still Very Underpriced
We last covered ISW Holdings Inc (OTCMKTS:ISWH) three weeks ago, noting at the time that it was poised as a hugely undervalued...
MAKE IT MODERN
